Accessible Across Europe for On the net Sales

VANCOUVER, Aug. 19, 2019 /CNW/ – Harvest One particular Cannabis Inc. (“Harvest One particular” or the “Business“) (TSXV: HVT OTCQX: HRVOF), by way of its wholly-owned subsidiary Satipharm Ltd. (“Satipharm“) now announced it has expanded its item portfolio with the launch of CBD oil, now obtainable on-line at www.satipharm.com. Brick and mortar distribution will adhere to with significant retailers all through Europe.

The new European oils plan has begun with a Lemon & Lime flavoured CBD oil. Satipharm expects to expand this plan with extra varieties in the coming months. Satipharm CBD oils join the current CBD Gelpell® capsules, currently obtainable across Europe on-line and in 1,800 retailers across the UK and Ireland.  All of Satipharm’s merchandise in Europe are EU GMP certified to assure the highest requirements.

The Satipharm Lemon & Lime CBD oil was especially formulated to address 3 significant issues from customers, which are taste, GMP certification, and reputable dosage.

“Product innovation is important to creating our brands. Our new CBD oil illustrates continued movement by Harvest One particular towards our method of creating wellness, wellness, and self-care brands about the globe,” mentioned Grant Froese, Chief Executive Officer of Harvest One particular. “Customers can have the identical self-assurance in new Satipharm CBD oils as they do in our current Satipharm CBD Gelpell® currently on the industry across Europe.”

Additional to Harvest One’s press release dated June 21, 2019 (See SEDAR for complete disclosure) in respect to a shares-for-solutions agreement, the Business has issued 131,710 common shares at a value of $.57 per share.

About Harvest One particular Cannabis

Harvest One particular is a worldwide customer packaged goods firm that develops and distributes premium wellness, wellness, and way of life merchandise to sufferers and customers in regulated markets about the globe. The Company’s portfolio of premium merchandise is made to boost good quality of life. Shareholders have important exposure to the complete cannabis worth chain by way of 4 wholly-owned subsidiaries: United Greeneries, a Licensed Producer Satipharm (health-related and nutraceutical) Dream Water Worldwide and Delivra (customer merchandise with an emphasis on sleep, discomfort, and anxiousness), and a minority interest in Burb Cannabis (retail operations). For extra facts, please check out www.harvestone.com.

About Satipharm

Satipharm is a wellness and wellness firm which is specialised in the improvement and manufacture of cannabinoid-primarily based merchandise from the cannabis plant. Our mission is to provide the highest good quality merchandise that are made especially with the wants of our shoppers in thoughts. For extra facts, please check out www.satipharm.com.

Cautionary Note With regards to Forward-Seeking Statements

Particular statements contained in this press release constitute forward-searching facts. These statements relate to future events or future overall performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and equivalent expressions and statements relating to matters that are not historical information are intended to determine forward-searching facts and are primarily based on the Company’s present belief or assumptions as to the outcome and timing of such future events. Actual future benefits could differ materially. The forward-searching facts contained in this press release is produced as of the date hereof, and the Business is not obligated to update or revise any forward-searching facts, whether or not as a outcome of new facts, future events or otherwise, except as needed by applicable securities laws. Since of the dangers, uncertainties and assumptions contained herein, investors should really not spot undue reliance on forward-searching facts. The foregoing statements expressly qualify any forward-searching facts contained herein.

Neither TSX-V nor its Regulation Solutions Provider (as that term is defined in the policies of the TSX-V) accept duty for the adequacy or accuracy of this release.

Harvest One Cannabis Inc. (CNW Group/Harvest One Cannabis Inc.)

Satipharm CBD (CNW Group/Harvest One Cannabis Inc.)

Cision View original content material to download multimedia:http://www.prnewswire.com/news-releases/harvest-1-launches-new-satipharm-cbd-oil-300903425.html

Supply Harvest One particular Cannabis Inc.

View original content material to download multimedia: http://www.newswire.ca/en/releases/archive/August2019/19/c1265.html

Colin Clancy, Vice President of Investor Relations, [email protected], 1-877-915-7934Copyright CNW Group 2019